Taipei Exchange - Delayed Quote TWD

LabTurbo Biotech Corporation (7725.TWO)

22.00
0.00
(0.00%)
At close: May 14 at 10:05:27 AM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
72,975
72,975
188,095
1,342,156
979,464
Cost of Revenue
55,953
55,953
156,967
346,708
295,060
Gross Profit
17,022
17,022
31,128
995,448
684,404
Operating Expense
199,534
199,534
209,879
197,055
100,204
Operating Income
-182,512
-182,512
-178,751
798,393
584,200
Net Non Operating Interest Income Expense
4,902
4,902
6,121
671
-560
Pretax Income
7,729
7,729
-55,233
822,674
578,680
Tax Provision
-5,234
-5,234
9,114
179,891
120,176
Net Income Common Stockholders
12,963
12,963
-64,347
642,783
458,504
Diluted NI Available to Com Stockholders
12,963
12,963
-64,347
642,783
458,504
Basic EPS
0.27
--
-1.33
13.30
10.21
Diluted EPS
0.27
--
-1.33
13.10
10.12
Basic Average Shares
48,011.11
--
48,381.20
48,327
44,897
Diluted Average Shares
48,011.11
--
48,381.20
49,052
45,328
Total Expenses
255,487
255,487
366,846
543,763
395,264
Net Income from Continuing & Discontinued Operation
12,963
12,963
-64,347
642,783
458,504
Normalized Income
12,555.80
12,555.80
-61,913.40
642,893.95
458,504
Interest Income
5,388
5,388
6,290
1,221
166
Interest Expense
486
486
169
550
726
Net Interest Income
4,902
4,902
6,121
671
-560
EBIT
8,215
8,215
-55,064
823,224
579,406
EBITDA
58,100
58,100
-8,867
865,021
599,638
Reconciled Cost of Revenue
55,953
55,953
156,967
346,708
295,060
Reconciled Depreciation
49,885
49,885
46,197
41,797
20,232
Net Income from Continuing Operation Net Minority Interest
12,963
12,963
-64,347
642,783
458,504
Total Unusual Items Excluding Goodwill
509
509
-3,042
-142
0
Total Unusual Items
509
509
-3,042
-142
0
Normalized EBITDA
57,591
57,591
-5,825
865,163
599,638
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
101.80
101.80
-608.40
-31.05
0
12/31/2021 - 12/22/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers